KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Gsk (GSK) Shares Issued (2016 - 2025)

Historic Shares Issued for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to $1.3 million.

  • Gsk's Shares Issued fell 9454.6% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $19.1 million, marking a year-over-year decrease of 6160.79%. This contributed to the annual value of $19.8 million for FY2025, which is 2262.63% down from last year.
  • Per Gsk's latest filing, its Shares Issued stood at $1.3 million for Q4 2025, which was down 9454.6% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Gsk's Shares Issued ranged from a high of $25.6 million in Q4 2021 and a low of $1.3 million during Q2 2024
  • In the last 5 years, Gsk's Shares Issued had a median value of $9.7 million in 2023 and averaged $11.7 million.
  • In the last 5 years, Gsk's Shares Issued skyrocketed by 32744.91% in 2022 and then tumbled by 9454.6% in 2025.
  • Quarter analysis of 5 years shows Gsk's Shares Issued stood at $25.6 million in 2021, then decreased by 8.41% to $23.5 million in 2022, then plummeted by 52.38% to $11.2 million in 2023, then surged by 118.31% to $24.4 million in 2024, then plummeted by 94.55% to $1.3 million in 2025.
  • Its Shares Issued stands at $1.3 million for Q4 2025, versus $2.7 million for Q2 2025 and $15.1 million for Q1 2025.